Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Assessing the Longitudinal Outcomes of Piperacillin/Tazobactam Versus Ceftriaxone and Metronidazole for Children With Perforated Appendicitis: A Multicentre Randomized Controlled Trial

NCT07869095 is registered in ClinicalTrials.gov with McMaster Children's Hospital as lead sponsor.

NCT NCT07869095
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07869095 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Assessing the Longitudinal Outcomes of Piperacillin/Tazobactam Versus Ceftriaxone and Metronidazole for Children With Perforated Appendicitis: A Multicentre Randomized Controlled Trial
Lead sponsor
McMaster Children's Hospital
Phase
Phase 3
Overall status
Not yet recruiting
Start date
April 30, 2027
Completion date
December 31, 2031
Enrollment
180 (estimated)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

antibiotic, appendectomy, laparoscopic, appendicitis perforated, pediatric, randomized controlled trial